| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 05/25/1999 | US5906917 Nucleic acid probes to mycobacterium tuberculosis |
| 05/25/1999 | US5906821 Viral nucleotide sequences |
| 05/25/1999 | US5906817 Biocompatible implant for the expression and in vivo secretion of a therapeutic substance |
| 05/25/1999 | CA2189646C A purified mixture of collagenases and two other proteases obtained from clostridium histolyticum |
| 05/25/1999 | CA2038011C Processes for preparing 2-halogeno-3-hydroxy-3-phenyl-propionic acid ester compounds |
| 05/25/1999 | CA1340563C Process for the multiple oxidation of steroids and genetically engineered cells to be used therefor |
| 05/25/1999 | CA1340557C Ckmb assay and monoclonal antibodies for use in same |
| 05/25/1999 | CA1340555C Oral vaccines |
| 05/21/1999 | CA2251257A1 Oncogene- or virus-controlled expression systems |
| 05/20/1999 | WO1999024597A1 Method for producing l-carnitine from crotonobetaine |
| 05/20/1999 | WO1999024586A1 Chimeric hydroxy-phenyl pyruvate dioxygenase, dna sequence and method for obtaining plants containing such a gene, with herbicide tolerance |
| 05/20/1999 | WO1999024585A1 Mutated hydroxy-phenyl pyruvate dioxygenase, dna sequence and method for obtaining herbicide-tolerant plants containing such gene |
| 05/20/1999 | WO1999024581A2 Plant-optimized genes encoding pesticidal toxins |
| 05/20/1999 | WO1999024576A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |
| 05/20/1999 | WO1999024567A1 Tissue cement proteins from rhipicephalus appendiculatus |
| 05/20/1999 | WO1999024559A2 Nuclear targeting by means of streptococcal protein h |
| 05/20/1999 | WO1999024448A2 New sophoroselipids, method for their production and use |
| 05/20/1999 | WO1999024068A1 Immortal avian cell line to grow avian and animal viruses to produce vaccines |
| 05/20/1999 | WO1999024052A2 Use of protein h as cytostatic agent |
| 05/20/1999 | WO1999023996A2 Compositions containing red rice fermentation products, frementation processes and monascus strains therefor |
| 05/20/1999 | WO1999018228A3 Method for microbial production of amino acids of the aspartate and/or glutamate family and agents which can be used in said method |
| 05/20/1999 | WO1999010481A3 Mutant thermomonospora spp. cellulase |
| 05/20/1999 | WO1999004014A3 Transformed yeast strains and their use for the production of monoterminal and diterminal aliphatic carboxylates |
| 05/20/1999 | WO1999004007A9 Increasing production of proteins in gram-positive microorganisms |
| 05/20/1999 | DE19749480A1 Verfahren zur Herstellung von L-Carnitin aus Crotonobetain A method for producing L-carnitine from crotonobetaine |
| 05/20/1999 | CA2314328A1 Method for producing l-carnitine from crotonobetaine |
| 05/20/1999 | CA2309640A1 Nuclear targeting by means of bacterial proteins |
| 05/20/1999 | CA2309559A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |
| 05/20/1999 | CA2309322A1 Mutated hydroxy-phenyl pyruvate dioxygenase, dna sequence and method for obtaining herbicide-tolerant plants containing such gene |
| 05/20/1999 | CA2309318A1 Chimeric hydroxy-phenyl pyruvate dioxygenase, dna sequence and method for obtaining plants containing such a gene, with herbicide tolerance |
| 05/19/1999 | EP0916735A1 Process for preparing 2,6-diaminopurine-2'-deoxyriboside and 2'-deoxyguanosine |
| 05/19/1999 | EP0916733A1 Procedure and kit for the cloning of fragments |
| 05/19/1999 | EP0916732A1 The engineering of electronic interactions at metal ion binding sites for the stabilization of proteins |
| 05/19/1999 | EP0916727A2 Novel LysS |
| 05/19/1999 | EP0916680A2 Lantibiotic related to Actagardine, process of preparation and use thereof |
| 05/19/1999 | EP0915988A1 Process for the fermentative production of deacylated cephalosporins |
| 05/19/1999 | EP0915977A1 B. burgdorferi polypeptides expressed in vivo |
| 05/19/1999 | EP0605627B1 Immunoassay for identifying alcoholics and monitoring alcohol consumption |
| 05/19/1999 | EP0574466B1 Expression of recombinant proteins in attenuated bacteria |
| 05/19/1999 | EP0552257B1 A plant protein useful for treating tumors and hiv infection |
| 05/19/1999 | EP0434747B1 RECOMBINANT VACCINES BASED ON THE gB-PROTEIN OF MAREK'S DISEASE VIRUS |
| 05/19/1999 | CN1217029A Prepn. of microbial polyunsaturated fatty acid contg. oil from pasteurised biomass |
| 05/19/1999 | CN1217027A Parapoxviruses contg. foreign DNA, their prodn. and their use in vacciens |
| 05/19/1999 | CN1217025A Processed polypeptides with IL-16 activity, process for preparing same and their use |
| 05/19/1999 | CN1217020A Alpha amylase mutants |
| 05/19/1999 | CN1216994A Apoptosis inducing molecule II |
| 05/19/1999 | CN1216922A Porcine reproductive and respiratory syndrome vaccine |
| 05/18/1999 | US5905142 Protease resistant PDGF and methods of use |
| 05/18/1999 | US5905040 Eukaryotic transfectants express self-assembled empty viral capsids which can be used to vaccinate against the virus or antigenically related species of the virus. |
| 05/18/1999 | US5905034 Method for precipitating natural avermectins |
| 05/18/1999 | US5905033 Process for obtaining a microbial culture medium from the entrails of fish, shellfish or cephalopods and culturing microorganisms using same |
| 05/18/1999 | CA2238657A1 A new protease |
| 05/18/1999 | CA2187250C Method for producing a soluble protein with bacteria |
| 05/18/1999 | CA2032191C Expression of the recombinant tumor necrosis factor binding protein i (tbp-i) |
| 05/18/1999 | CA1340548C Method for producing native hiv gp160 |
| 05/18/1999 | CA1340547C Novel secretory leader sequences for yeasts |
| 05/18/1999 | CA1340544C Human tissue factor related dna segments, polypeptides and antibodies |
| 05/18/1999 | CA1340542C Molecular cloning and characterization of a gene sequence coding for human relaxin |
| 05/17/1999 | CA2238669A1 A new transcriptional regulatory factor |
| 05/17/1999 | CA2238666A1 Translational controlling protein for cathepsin b mrna |
| 05/14/1999 | WO1999023238A1 Efficient construction of vectors for gene targeting using phage-plasmid recombination |
| 05/14/1999 | WO1999023229A1 A method of inhibiting an immune response to a recombinant vector |
| 05/14/1999 | WO1999023227A2 Hyaluronan synthase gene and uses thereof |
| 05/14/1999 | WO1999023216A2 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
| 05/14/1999 | WO1999023212A1 Novel streptococcal ers |
| 05/14/1999 | WO1999023211A1 α-AMYLASE MUTANTS |
| 05/14/1999 | WO1998014593A9 Human telomerase catalytic subunit |
| 05/14/1999 | CA2845178A1 .alpha.-amylase mutants |
| 05/14/1999 | CA2308575A1 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
| 05/14/1999 | CA2308119A1 .alpha.-amylase mutants |
| 05/14/1999 | CA2308031A1 Efficient construction of vectors for gene targeting using phage-plasmid recombination |
| 05/14/1999 | CA2308017A1 A method of inhibiting an immune response to a recombinant vector |
| 05/13/1999 | CA2254010A1 Assays for measurement of protein fragments in biological media |
| 05/12/1999 | EP0915168A1 Process for producing maturation bone morphogenetic protein |
| 05/12/1999 | EP0915166A1 DNA virus vectors and methods for their production |
| 05/12/1999 | EP0915165A1 Method for the helper virus-free packaging of a DNA-vector |
| 05/12/1999 | EP0915163A1 GENE ENCODING $g(b)-GALACTOSIDE $g(a)-2,6-SIALYLTRANSFERASE |
| 05/12/1999 | EP0915162A2 Adenine phosphoribosyltransferase |
| 05/12/1999 | EP0915157A2 Method for the preparation of functional recombinant tissue factor |
| 05/12/1999 | EP0915154A1 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
| 05/12/1999 | EP0915153A1 $g(b)-GALACTOSIDE $G(a)-2,6-SIALYLTRANSFERASE |
| 05/12/1999 | EP0915061A1 Method for reducing the effect of detergents upon germination and/or growth of micro-organisms |
| 05/12/1999 | EP0914610A1 Screen for ecdysone receptor ligands |
| 05/12/1999 | EP0914463A2 NOVEL PROCESS FOR THE PREPARATION OF CEPHALOSPORINS USING $i(ACREMONIUM CHRYSOGENUM) |
| 05/12/1999 | EP0914458A1 Living recombinant avian vaccine, using as a vector the infectious avian laryngotracheitis virus |
| 05/12/1999 | EP0914451A1 Il-1/tnf-alpha-activated kinase (itak), and methods of making and using the same |
| 05/12/1999 | EP0914439A2 Pesticidal toxins |
| 05/12/1999 | EP0914431A2 Truncated soluble tumor necrosis factor type-i and type-ii receptors |
| 05/12/1999 | EP0914430A2 Polynucleotides from human fetal brain encoding secreted proteins |
| 05/12/1999 | EP0914423A2 Inhibition of hiv-1 replication by antisense rna expression |
| 05/12/1999 | EP0914418A1 Method for producing therapeutic dna |
| 05/12/1999 | EP0914344A1 ASSAY AND REAGENTS FOR QUANTIFYING hBNP |
| 05/12/1999 | EP0914330A1 Novel compounds |
| 05/12/1999 | EP0914328A1 STREPTOCOCCUS PNEUMONIAE ALANYL tRNA SYNTHETASE |
| 05/12/1999 | EP0914327A1 NOVEL LysS PROTEINS FROM STREPTOCOCCUS PNEUMONIAE |
| 05/12/1999 | EP0914150A1 Recombinant neospora antigens and their uses |
| 05/12/1999 | EP0914149A1 Purification and characterization of alkaline phosphatase from thermotoga neapolitana |
| 05/12/1999 | EP0914043A1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 05/12/1999 | EP0785727B1 Preparation of frozen fermented foods using antifreeze polypeptide-expressing microorganisms |
| 05/12/1999 | EP0751940B1 Sesquiterpenic derivatives |